Pharma giant Merck raises 2020 outlook, saying the worst of the coronavirus impact is behind itCNBC • 07/31/20
Merck Announces Two US Regulatory Milestones for KEYTRUDA® (pembrolizumab) in Triple-Negative Breast Cancer (TNBC)Business Wire • 07/30/20
How Much Will Coronavirus Hurt Merck's (MRK) Q2 Earnings? (Revised)Zacks Investment Research • 07/30/20
FDA Grants Breakthrough Therapy Designation to Merck’s Novel HIF-2α Inhibitor MK-6482 for Treatment of Certain Patients With Von Hippel-Lindau Disease- Associated Renal Cell CarcinomaBusiness Wire • 07/29/20
Pharma executives promise Congress they aren't cutting corners in fast tracking coronavirus vaccineCNBC • 07/21/20
Dow Jones Giant Merck Inks A New Deal In Lung Cancer — And Shares PopInvestors Business Daily • 07/15/20
Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for YouThe Motley Fool • 07/14/20